Pfizer
This article was originally published in The Rose Sheet
Executive Summary
Successful launches of Lubriderm Skin Renewal face and body care in July and Listerine PocketPaks in September helped drive consumer health care division sales up 6% to $602 mil. in third quarter, firm announces. Sales increased 8% excluding impact of foreign currency. Strong growth of Benadryl and Sudafed also contributed to division's sales increase for the quarter. Shaving product sales were down 8% to $183 mil., or 3% excluding impact of foreign exchange. Sales declines in older products were partially offset by strong sales of Xtreme III triple blade razor, which was introduced to European markets earlier this year, Pfizer said